Ettore Gilardoni

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Venues

Antibodies (Basel, Switzerland)

Pharmaceutics

Bioconjugate chemistry

Analytical chemistry

Università degli Studi di Milano (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Università degli Studi di Milano Oct 01 2017

Italy

PHD :: Departement of Pharmaceutical Sciences

Università degli Studi di Milano Oct 01 2012 - Jul 18 2017

Italy

MSC :: Departement of Pharmaceutical Sciences

Publications

Sara Puglioli, Mosè Fabbri, Claudia Comacchio, Laura Alvigini, Roberto De Luca, Sebastian Oehler, Ettore Gilardoni, Gabriele Bassi, Samuele Cazzamalli, Dario Neri, Nicholas Favalli
Permutational Encoding Strategy Accelerates HIT Validation from Single-Stranded DNA-Encoded Libraries. Bioconjugate chemistry 35 (7) (2024)
Sara Puglioli, Mosè Fabbri, Claudia Comacchio, Laura Alvigini, Roberto De Luca, Sebastian Oehler, Ettore Gilardoni, Gabriele Bassi, Samuele Cazzamalli, Dario Neri, Nicholas Favalli
Permutational Encoding Strategy Accelerates HIT Validation from Single-Stranded DNA-Encoded Libraries. Bioconjugate chemistry (2024)
Aureliano Zana, Claudia Puig-Moreno, Matilde Bocci, Ettore Gilardoni, Cesare Di Nitto, Lucrezia Principi, Domenico Ravazza, Giulia Rotta, Eleonora Prodi, Roberto De Luca, Dario Neri, Samuele Cazzamalli
A Comparative Analysis of Fibroblast Activation Protein-Targeted Small Molecule-Drug, Antibody-Drug, and Peptide-Drug Conjugates. Bioconjugate chemistry (2023)
Eleonora Prodi, Claudia Comacchio, Ettore Gilardoni, Cesare Di Nitto, Emanuele Puca, Dario Neri, Roberto De Luca
An Antibody Targeting Fibroblast Activation Protein Simultaneously Fused to Interleukin-2 and Tumor Necrosis Factor Selectively Localizes to Neoplastic Lesions. Antibodies (Basel, Switzerland) 12 (2) (2023)
Eleonora Prodi, Claudia Comacchio, Ettore Gilardoni, Cesare Di Nitto, Emanuele Puca, Dario Neri, Roberto De Luca
An Antibody Targeting Fibroblast Activation Protein Simultaneously Fused to Interleukin-2 and Tumor Necrosis Factor Selectively Localizes to Neoplastic Lesions. Antibodies (Basel, Switzerland) 12 (2) (2023)
Eleonora Prodi, Claudia Comacchio, Ettore Gilardoni, Cesare Di Nitto, Emanuele Puca, Dario Neri, Roberto De Luca
An Antibody Targeting Fibroblast Activation Protein Simultaneously Fused to Interleukin-2 and Tumor Necrosis Factor Selectively Localizes to Neoplastic Lesions. Antibodies (Basel, Switzerland) 12 (2) (2023)
Cesare Di Nitto, Ettore Gilardoni, Jacqueline Mock, Lisa Nadal, Tobias Weiss, Michael Weller, Frauke Seehusen, Chiara Libbra, Emanuele Puca, Dario Neri, Roberto De Luca
An Engineered IFNγ-Antibody Fusion Protein with Improved Tumor-Homing Properties. Pharmaceutics 15 (2) (2023)
Cesare Di Nitto, Ettore Gilardoni, Jacqueline Mock, Lisa Nadal, Tobias Weiss, Michael Weller, Frauke Seehusen, Chiara Libbra, Emanuele Puca, Dario Neri, Roberto De Luca
An Engineered IFNγ-Antibody Fusion Protein with Improved Tumor-Homing Properties. Pharmaceutics 15 (2) (2023)
Cesare Di Nitto, Ettore Gilardoni, Jacqueline Mock, Lisa Nadal, Tobias Weiss, Michael Weller, Frauke Seehusen, Chiara Libbra, Emanuele Puca, Dario Neri, Roberto De Luca
An Engineered IFNγ-Antibody Fusion Protein with Improved Tumor-Homing Properties. Pharmaceutics 15 (2) (2023)
Eleonora Prodi, Claudia Comacchio, Ettore Gilardoni, Cesare Di Nitto, Emanuele Puca, Dario Neri, Roberto De Luca
An Antibody Targeting Fibroblast Activation Protein Simultaneously Fused to Interleukin-2 and Tumor Necrosis Factor Selectively Localizes to Neoplastic Lesions. Antibodies (Basel, Switzerland) 12 (2) (2023)
Eleonora Prodi, Claudia Comacchio, Ettore Gilardoni, Cesare Di Nitto, Emanuele Puca, Dario Neri, Roberto De Luca
An Antibody Targeting Fibroblast Activation Protein Simultaneously Fused to Interleukin-2 and Tumor Necrosis Factor Selectively Localizes to Neoplastic Lesions. Antibodies (Basel, Switzerland) 12 (2) (2023)
Cesare Di Nitto, Ettore Gilardoni, Jacqueline Mock, Lisa Nadal, Tobias Weiss, Michael Weller, Frauke Seehusen, Chiara Libbra, Emanuele Puca, Dario Neri, Roberto De Luca
An Engineered IFNγ-Antibody Fusion Protein with Improved Tumor-Homing Properties. Pharmaceutics 15 (2) (2023)
Ettore Gilardoni, Aureliano Zana, Andrea Galbiati, Theo Sturm, Jacopo Millul, Samuele Cazzamalli, Dario Neri, Riccardo Stucchi
Mass Spectrometry-Based Method for the Determination of the Biodistribution of Tumor-Targeting Small Molecule-Metal Conjugates. Analytical chemistry 94 (30) (2022)
Aureliano Zana, Andrea Galbiati, Ettore Gilardoni, Matilde Bocci, Jacopo Millul, Theo Sturm, Riccardo Stucchi, Abdullah Elsayed, Lisa Nadal, Martina Cirillo, Wolfgang Roll, Lars Stegger, Inga Asmus, Philipp Backhaus, Michael Schäfers, Dario Neri, Samuele Cazzamalli
Fibroblast Activation Protein triggers release of drug payload from non-internalizing small molecule-drug conjugates in solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Matteo Mori, Ettore Gilardoni, Luca Regazzoni, Alessandro Pedretti, Diego Colombo, Gary N Parkinson, Akira Asai, Fiorella Meneghetti, Stefania Villa, Arianna Gelain
Towards the Inhibition of Protein-Protein Interactions (PPIs) in STAT3: Insights into a New Class of Benzothiadiazole Derivatives. Molecules (Basel, Switzerland) 25 (15) (2020)
Inge Everaert, Giovanna Baron, Silvia Barbaresi, Ettore Gilardoni, Crescenzo Coppa, Marina Carini, Vistoli Giulio, Tine Bex, Jan Stautemas, Laura Blancquaert, Wim Derave, Giancarlo Aldini, Luca Regazzoni
Development and validation of a sensitive LC-MS/MS assay for the quantification of anserine in human plasma and urine and its application to pharmacokinetic study. Amino acids 51 (1) (2018)

Ettore Gilardoni.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ettore Gilardoni